{"id":"W4281787542","doi":"10.1200/jco.2022.40.16_suppl.9573","title":"SALVO: Single-arm trial of ipilimumab and nivolumab as adjuvant therapy for resected mucosal melanoma.","year":2022,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group","funders":"","keywords":"Medicine; Ipilimumab; Nivolumab; Adjuvant; Melanoma; Internal medicine; Clinical endpoint; Adjuvant therapy; Concomitant; Oncology; Radiation therapy; Clinical trial; Surgery; Cancer; Gastroenterology; Immunotherapy; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001581407,0.001673694,0.001412879,0.0003477605,0.0003233246,0.0009284402,0.000801674,0.001192629,0.006362398],"category_scores_gemma":[0.0009558299,0.000482232,0.00205185,0.0002326968,0.000894101,0.0007283026,0.0005120522,0.002193221,0.001142733],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006519874,"about_ca_system_score_gemma":0.001153049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007911341,"about_ca_topic_score_gemma":0.00213853,"domain_scores_codex":[0.9995528,0.0002412546,0.00002043478,0.00007362721,0.00003371234,0.00007821873],"domain_scores_gemma":[0.9994584,0.00009721294,0.0001298062,0.00004885047,0.00002499549,0.0002407947],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.9665787,0.005190607,0.0009433233,0.0007567245,0.00101121,0.00006022061,0.00006947061,0.0004710065,0.005469981,0.0002369431,0.001470909,0.01774098],"study_design_scores_gemma":[0.911528,0.0828538,0.002201787,0.00004758004,0.0005562177,0.0000576036,0.00002638986,0.0004898438,0.0006350737,0.0001973156,0.001392909,0.00001351092],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9834674,0.005640999,0.0006037235,0.001261682,0.0007852,0.00282165,0.001398371,0.0001454333,0.003875677],"genre_scores_gemma":[0.9804658,0.002464238,0.001765127,0.001452607,0.0006280095,0.004697271,0.002011945,0.00003710216,0.006477865],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006362398,"threshold_uncertainty_score":0.0212844,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1452594771967141,"score_gpt":0.460658767907029,"score_spread":0.3153992907103148,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}